Fc epsilon receptor, a specific differentiation marker transiently expressed on mature B cells before isotype switching - PubMed (original) (raw)

Fc epsilon receptor, a specific differentiation marker transiently expressed on mature B cells before isotype switching

H Kikutani et al. J Exp Med. 1986.

Abstract

The expression of Fc epsilon R on human lymphocytes was studied with the anti-Fc epsilon R mAbs. Fc epsilon R was expressed on most mu+,delta+ circulating B cells, whereas T cells did not express Fc epsilon R even in patients with hyper-IgE syndrome. B cells with gamma, alpha, or epsilon phenotype did not express Fc epsilon R, moreover its expression could not be induced, suggesting that the Fc epsilon R expression was correlated with isotype switching. mu+delta+ B cells in bone marrow did not express Fc epsilon R, but PHA-sup (supernatant from PHA-stimulated cell cultures) could induce its expression, and the addition of IgE augmented this induction. Recombinant IL-2, IL-1, IFN-gamma or -beta, or purified B cell differentiation factor (BSF-2 B cell-stimulatory factor 2) could not induce Fc epsilon R expression in bone marrow B cells. IFN-gamma inhibited the Fc epsilon R expression induced by PHA-sup, suggesting that the human counterpart of BSF-1 may be responsible for Fc epsilon R expression in bone marrow B cells. B cells from patients with common variable immunodeficiency and ataxia telangiectasia did not express Fc epsilon R, but PHA-sup could induce its expression, indicating that circulating B cells of these patients are at a differentiation stage similar to B cells in bone marrow. The study showed that Fc epsilon R is a B cell-specific differentiation marker, the expression of which is restricted to a defined stage of B cell differentiation.

PubMed Disclaimer

Similar articles

• Monoclonal anti-Fc epsilon receptor antibodies with different specificities and studies on the expression of Fc epsilon receptors on human B and T cells.
  Suemura M, Kikutani H, Barsumian EL, Hattori Y, Kishimoto S, Sato R, Maeda A, Nakamura H, Owaki H, Hardy RR, et al. Suemura M, et al. J Immunol. 1986 Aug 15;137(4):1214-20. J Immunol. 1986. PMID: 2426355
• Murine B-cell stimulatory factor 1 (interleukin 4) increases expression of the Fc receptor for IgE on mouse B cells.
  Hudak SA, Gollnick SO, Conrad DH, Kehry MR. Hudak SA, et al. Proc Natl Acad Sci U S A. 1987 Jul;84(13):4606-10. doi: 10.1073/pnas.84.13.4606. Proc Natl Acad Sci U S A. 1987. PMID: 2955412 Free PMC article.
• CD23/Fc epsilon RII expression on phytohemagglutinin-A- or phorbol-12myristate-13acetate-Ca(2+)-activated human tonsil T cells.
  Carini C, Pini C, DiFelice G, Fattorossi A, Fratazzi C. Carini C, et al. Int Arch Allergy Immunol. 1993;101(1):31-8. doi: 10.1159/000236495. Int Arch Allergy Immunol. 1993. PMID: 8499771
• IgE class-specific regulatory factor(s) and Fc epsilon receptors on lymphocytes.
  Suemura M, Kishimoto T. Suemura M, et al. Int Rev Immunol. 1987 Jan;2(1):27-42. doi: 10.3109/08830188709044745. Int Rev Immunol. 1987. PMID: 2976798 Review.
• The expression of IgE Fc receptors on lymphocytes of allergic patients.
  Spiegelberg HL. Spiegelberg HL. Int Rev Immunol. 1987 Jan;2(1):63-74. doi: 10.3109/08830188709044747. Int Rev Immunol. 1987. PMID: 2976800 Review.

Cited by

• Soluble CD23 (Fc epsilon RII) and interleukin 1 synergistically induce early human thymocyte maturation.
  Mossalayi MD, Lecron JC, Dalloul AH, Sarfati M, Bertho JM, Hofstetter H, Delespesse G, Debre P. Mossalayi MD, et al. J Exp Med. 1990 Mar 1;171(3):959-64. doi: 10.1084/jem.171.3.959. J Exp Med. 1990. PMID: 2137858 Free PMC article.
• The receptor for the Fc region of IgE.
  Keegan AD, Conrad DH. Keegan AD, et al. Springer Semin Immunopathol. 1990;12(4):303-26. doi: 10.1007/BF00225321. Springer Semin Immunopathol. 1990. PMID: 2151402 Review. No abstract available.
• Gene mapping of mouse IL-4 receptor: the loci of interleukin 4 (IL-4) receptor gene and lymphocyte function associated antigen 1 (LFA-1) gene are closely linked on chromosome 7.
  Suzuki H, Chung FZ, Palmer E, Sasaki T, Ohara N, Taylor BA, Ohara J. Suzuki H, et al. Immunogenetics. 1991;34(4):252-6. doi: 10.1007/BF00215261. Immunogenetics. 1991. PMID: 1680807 No abstract available.
• In vitro and in vivo model of a novel immunotherapy approach for chronic lymphocytic leukemia by anti-CD23 chimeric antigen receptor.
  Giordano Attianese GM, Marin V, Hoyos V, Savoldo B, Pizzitola I, Tettamanti S, Agostoni V, Parma M, Ponzoni M, Bertilaccio MT, Ghia P, Biondi A, Dotti G, Biagi E. Giordano Attianese GM, et al. Blood. 2011 May 5;117(18):4736-45. doi: 10.1182/blood-2010-10-311845. Epub 2011 Mar 15. Blood. 2011. PMID: 21406718 Free PMC article.
• Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
  Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E. Wang F, et al. J Virol. 1990 May;64(5):2309-18. doi: 10.1128/JVI.64.5.2309-2318.1990. J Virol. 1990. PMID: 2157887 Free PMC article.

References

1. 1. J Immunol. 1975 Oct;115(4):982-7 - PubMed
2. 1. J Immunol. 1983 Dec;131(6):2751-6 - PubMed
3. 1. J Clin Invest. 1977 Apr;59(4):616-24 - PubMed
4. 1. J Immunol. 1979 Jun;122(6):2577-83 - PubMed
5. 1. J Clin Invest. 1979 Sep;64(3):714-20 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program